Moderna (MRNA) collaborates with Generation Bio to develop non-viral genetic medicines. For this, it leverages the latters closed-end DNA (ceDNA)…
Moderna Inc. stock underperforms Friday when compared to competitors despite daily gains...…
CAMBRIDGE, MA / ACCESSWIRE / March 24, 2023 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics…
Moderna Inc. stock rises Thursday, still underperforms market...…
... sales)
March 23 (Reuters) - Moderna Inc has entered a
licensing deal......…
Shares of Generation Bio Co. GBIO jumped about 28% premarket trading on Thursday after the company announced a collaboration with…
...(Reuters) - Moderna Inc said on Thursday it had entered......…
Generation Bio, Moderna Enter Collaboration to Accelerate Non-Viral Genetic-Medicines Pipeline...…
Collaboration will extend the applications of each companys platform through discovery and development of novel lipid nanoparticles using Generation Bios…
Remember when they used to be free? As the US government winds down its pandemic emergency spending, health giant Moderna…
Moderna Inc. stock underperforms Wednesday when compared to competitors...…
Bernie Sanders pressed Stephane Bancel during the Senate hearing to make a commitment that Moderna will not increase the vaccines…
Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
The company is preparing for commercial distribution of the shots as the U.S. winds down its pandemic-emergency purchases....…
...(Adds details from hearing, background)
March 22 (Reuters) - Moderna......…
...March 22 (Reuters) -
Moderna Inc will no longer have the economies......…
The Boston biotech company plans to charge $130 per dose once the vaccination program moves to the private market as…
Moderna Inc. stock falls Tuesday, underperforms market...…
Moderna might become a multiproduct company over the next few years....…
Sen. Bernie Sanders is expected to focus on the company's plans to charge insurers $130 per dose for its Covid-19…
From now on, Moderna Inc (NASDAQ: MRNA) expects to charge $130 per dose for its COVID-19 vaccine as purchases move from the…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
...By Patrick Wingrove
(Reuters) - Moderna Inc expects to price its......…
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Moderna Inc. stock rises Monday, outperforms market...…
Moderna Inc. stock underperforms Friday when compared to competitors...…
An approved RSV vaccine could be the next big thing for these companies....…
Moderna Inc. stock rises Thursday, still underperforms market...…
Moderna shares have lost about 15% so far this year....…
Moderna Inc. stock underperforms Wednesday when compared to competitors...…
Zacks.com users have recently been watching Moderna (MRNA) quite a bit. Thus, it is worth knowing the facts that could…
Judge Rejects Request From Moderna, Moving Key COVID-19 Vaccine Case To Discovery
…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
CAMBRIDGE, MA / ACCESSWIRE / March 14, 2023 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics…
Moderna Inc. stock rises Tuesday, outperforms market...…
Tuesdays top analyst upgrades and downgrades included Ally Financial, Amgen, Baidu, Bilibili, Bill.com, Coinbase Global, Eli Lilly, GE Healthcare Technologies,…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Moderna Inc. stock rises Monday, outperforms market...…
The market takes a prognosticators new buy recommendation to heart....…
These are the stocks posting the largest moves midday....…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
New York (www.aktiencheck.de) - Moderna-Aktienanalyse von TD Cowen:
Die Analysten von TD Cowen raten in einer aktuellen Aktienanalyse zum Kauf der…
Dr James Fox explores whether Moderna shares would have been a good investment two years ago, and takes a closer…
Moderna (MRNA) closed at $138.29 in the latest trading session, marking a +0.68% move from the prior day....…
...By Blake Brittain
(Reuters) - Despite the backing of the U.S......…
Bancel, Stephane - Vorstand - Tag der Transaktion: 2023-03-08...…
Bancel, Stephane - Vorstand - Tag der Transaktion: 2023-03-09...…
Moderna Inc. stock rises Friday, outperforms market...…
...(Recasts lede, adds shares, background)
March 10 (Reuters) - Moderna......…